Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Boehringer Ingelheim
Express Scripts
Dow
Moodys

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

Sulfamethoxazole; trimethoprim - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic sources for sulfamethoxazole; trimethoprim and what is the scope of freedom to operate?

Sulfamethoxazole; trimethoprim is the generic ingredient in twenty-two branded drugs marketed by Sun Pharm Inds Inc, Monarch Pharms, Abraxis Pharm, Anda Repository, Bedford, Hospira, Mylan Labs Ltd, Teva Pharms Usa, Watson Labs, West-ward Pharms Int, Sun Pharm Industries, Ani Pharms Inc, Aurobindo Pharma, Hi Tech Pharma, Lannett Co Inc, Teva, Pharm Assoc, Usl Pharma, Alpharma Us Pharms, Naska, Novel Labs Inc, Amneal Pharms Ny, Chartwell Molecules, Fosun Pharma, Glenmark Generics, Heather, Interpharm, Martec Usa Llc, Mutual Pharm, Pliva, Roxane, Vista Pharms, Heritage Pharma, Superpharm, and Shionogi, and is included in sixty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-seven drug master file entries for sulfamethoxazole; trimethoprim. Fifty-five suppliers are listed for this compound.

Summary for sulfamethoxazole; trimethoprim
Recent Clinical Trials for sulfamethoxazole; trimethoprim

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Hvidovre University HospitalPhase 3
Bin DuPhase 4
University of PennsylvaniaPhase 1/Phase 2

See all sulfamethoxazole; trimethoprim clinical trials

Synonyms for sulfamethoxazole; trimethoprim
117385-88-3
37341-72-3
38916-35-7
4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide; 5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
4-AMINO-N-(5-METHYL-3-ISOXAZOLYL)-BENZENESULFONAMIDE COMPOUND WITH 5-(3,4,5-TRIMETHOXYBENZYL)PYRIMIDINE-2,4-DIAMINE
4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide; 5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine
50641-67-3
50808-41-8
52499-85-1
74711-00-5
8064-90-2
8064-91-3
8076-73-1
A 033
AC1L7D1P
AKOS030548395
Benzenesulfonamide, 4-amino-N-(5-methyl-3-isoxazolyl)- & 5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine
Benzenesulfonamide, mixt. with 5-[(3,4,5-trimethoxyphenyl)methyl]-2,4- pyrimidinediamine
CHEBI:3770
CHEMBL58061
Co-Trimazole
CO-Trimoxazole
Co-Trimoxazole (BAN)
Cotrim.L.U.T.
CTK4J2930
D00285
Epitope ID:141805
LS-178642
NSC-618652
NSC618652
SCHEMBL870329
SMX / TMP
SMX-TMP
SMX/TMP
Sulfameth/TMP
Sulfameth/Trimeth
Sulfamethoxazol-trimethoprim
Sulfamethoxazole - trimethoprim mixt
Sulfamethoxazole - trimethoprim mixture
Sulfamethoxazole / TMP
Sulfamethoxazole / trimethoprim
SULFAMETHOXAZOLE AND TRIMETHOPRIM
SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH
SULFAMETHOXAZOLE AND TRIMETHOPRIM SINGLE STRENGTH
Sulfamethoxazole mixture with trimethoprim
Sulfamethoxazole Trimethoprim
Sulfamethoxazole-trimeth
Sulfamethoxazole-trimethoprim
SXT
TMP / SMX
TMP & SMX
TMP-SMX
TMP/SMX
Trimethoprim & Sulfamethoxazole
Trimethoprim and sulfamethoxazole
Trimethoprim and sulphamethoxazole
Trimethoprim-sulfamethoxazole
Trimethoprim-sulfamethoxazole combination
Trimethoprim, Sulfamethoxazole Drug Combination
TRIMETHOPRIM/SULFAMETHOXAZOLE
Trimethoprimsulfa
Trimforte
Trimosulfa
WZRJTRPJURQBRM-UHFFFAOYSA-N

US Patents and Regulatory Information for sulfamethoxazole; trimethoprim

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lannett Co Inc SULFAMETHOXAZOLE AND TRIMETHOPRIM sulfamethoxazole; trimethoprim SUSPENSION;ORAL 077785-001 Jan 24, 2007 AB RX No No   Start Trial   Start Trial   Start Trial
Fosun Pharma SULFAMETHOXAZOLE AND TRIMETHOPRIM sulfamethoxazole; trimethoprim TABLET;ORAL 018598-003 May 19, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Sun Pharm Industries BACTRIM sulfamethoxazole; trimethoprim TABLET;ORAL 017377-001 Approved Prior to Jan 1, 1982 AB RX Yes No   Start Trial   Start Trial   Start Trial
Vista Pharms SULFAMETHOXAZOLE AND TRIMETHOPRIM sulfamethoxazole; trimethoprim TABLET;ORAL 076817-001 Oct 7, 2005 AB RX No No   Start Trial   Start Trial   Start Trial
Watson Labs SULFAMETHOXAZOLE AND TRIMETHOPRIM sulfamethoxazole; trimethoprim TABLET;ORAL 018852-001 May 9, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for sulfamethoxazole; trimethoprim

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sun Pharm Inds Inc BACTRIM sulfamethoxazole; trimethoprim INJECTABLE;INJECTION 018374-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Sun Pharm Industries BACTRIM PEDIATRIC sulfamethoxazole; trimethoprim SUSPENSION;ORAL 017560-002 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Sun Pharm Industries BACTRIM sulfamethoxazole; trimethoprim TABLET;ORAL 017377-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Monarch Pharms SEPTRA DS sulfamethoxazole; trimethoprim TABLET;ORAL 017376-002 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Monarch Pharms SEPTRA sulfamethoxazole; trimethoprim TABLET;ORAL 017376-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
AstraZeneca
Mallinckrodt
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.